Chicago Equity Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-47,940
Closed -$1.52M 941
2019
Q2
$1.52M Sell
47,940
-19,875
-29% -$623K 0.07% 409
2019
Q1
$2.24M Sell
67,815
-2,780
-4% -$86.5K 0.09% 318
2018
Q4
$2.27M Sell
70,595
-1,390
-2% -$52.4K 0.09% 312
2018
Q3
$3.09M Buy
71,985
+17,345
+32% +$820K 0.09% 299
2018
Q2
$2.52M Buy
54,640
+4,225
+8% +$187K 0.08% 342
2018
Q1
$2M Buy
50,415
+25,900
+106% +$959K 0.06% 379
2017
Q4
$821K Sell
24,515
-8,900
-27% -$316K 0.03% 539
2017
Q3
$1.24M Sell
33,415
-4,845
-13% -$182K 0.04% 469
2017
Q2
$1.42M Buy
38,260
+24,890
+186% +$813K 0.04% 434
2017
Q1
$376K Buy
+13,370
New +$377K 0.01% 636

Other funds holding PAHC

Chicago Equity Partners's PAHC Position: Q3 2019 in Review

Chicago Equity Partners sold out of Phibro Animal Health (PAHC) in Q3 2019, closing a stake of 47,940 shares — an estimated $1.52M sold.

Chicago Equity Partners first reported a position in PAHC in Q1 2017 and held it in 10 quarters. The position peaked at $3.09M in Q3 2018. 153 funds tracked by Wall St. Rank hold PAHC as of Q3 2019.

  • Chicago Equity Partners reported no remaining Phibro Animal Health position as of Q3 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 47,940 Phibro Animal Health shares in Q3 2019, an estimated $1.52M.
  • Chicago Equity Partners first reported a position in Phibro Animal Health in Q1 2017 and held it in 10 quarters.
  • Chicago Equity Partners's Phibro Animal Health position peaked at $3.09M in Q3 2018.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2019.

Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.